Category Archives: Chantix

Featured Stories
What Action Will the FDA Take on E-cigarettes?

What Action Will the FDA Take on E-cigarettes?

As health and quality concerns trouble the e-cigarette industry, experts and the public await the Food and Drug Administration (FDA)’s action to regulate the devices.

Read More

British Recall of Smith & Nephew Renasys Wound Care System

British Recall of Smith & Nephew Renasys Wound Care System for Infection Risk

The MHRA announced the recall of Smith & Nephew Renasys wound care devices - risk of maceration, infection, loss of negative pressure, or unrecognized bleeding in wounds.

Read More

Federal DePuy ASR Hip Implant Trials Likely to Start This Year

It looks as though the first trials in the DePuy ASR hip implant multidistrict litigation could begin sometime later this year. According to a report from Bloomberg News, during a status conference held yesterday in Florida, attorneys for both plaintiffs and the defense told U.S. District Judge David Katz that ...

Read More

FDA Advisory Panel Wrestling with Metal-on-Metal Hip Replacement Safety

An advisory panel for the U.S. Food & Drug Administration (FDA) began a highly-anticipated meeting yesterday to discuss the safety of metal-on-metal hip implants. Among other things, the panel of outside experts is being asked to make recommendations regarding the best practices for monitoring patients with metal-on-metal hip replacements. ...

Read More

Study Links Liquid in E-Cigarette to Viral Infections

Study Links Liquid in Electronic Cigarette to Increased Risk of Viral Infections

The National Jewish Health study, links the liquid used in e-cigarettes to a higher risk of respiratory viral infections, whether the liquid contains nicotine or not.

Read More

Older Patients Face Heart Attack Risk Following Surgery

Older Hip Implant, Knee Replacement Patients Face Heart Attack Risk Following Surgery

An emerging report reveals that older hip implant and knee replacement patients face increased heart attack risks following surgery. The risk for acute myocardial infarction (AMI) was seen in the first two weeks after these surgical procedures.

Read More

Geodon the antipsychotic drug can Cause Deadly Skin Reaction

Geodon can Cause Deadly Skin Reaction, FDA Warns

The FDA has required a new warning label for the antipsychotic drug Geodon (ziprasidone) to include the risk of a potentially fatal skin reaction.

Read More

FDA Advisors Set to Examine Metal-on-Metal Hip Implant Safety Concerns

Thousands of people with metal-on-metal hip implant devices could soon get some answers from the U.S. Food & Drug Administration (FDA) about the dangers they face. Tomorrow, the agency will convene a panel of outside medical experts to examine the safety record of metal-on-metal hip replacements, and recommend the ...

Read More

Three Injured, Long Island Railroad Train Hits Car on Tracks

Three Injured When Long Island Railroad Train Hits Car on Tracks

Three people, including a train engineer, were injured on Wednesday when a Long Island Rail Road train hit a livery cab on the tracks west of Wyandanch station, LIRR officials said. LIRR spokesman Salvatore Arena said the driver of the Lincoln Town Car was taken to Good Samaritan Hospital Medical Center ...

Read More

FDA Scrutinizes Pfizer Study Evaluating Chantix Suicide Risks

FDA Scrutinizes Pfizer Study Detailing Chantix Suicide Risks

The U.S. Food and Drug Administration (FDA) is questioning whether or not Pfizer’s study of neuropsychiatric effects of Chantix, the smoking cessation drug, accurately reflects the risks. Pfizer conducted the clinical trial upon request from the FDA, following a high … Continue reading

Posted in Chantix, Pharmaceuticals | Tagged , , , , , , , |

Expert Witness in Chantix Case Seeks Pfizer Documents

An expert witness in the multidistrict litigation over Chantix (varenicline), a smoking cessation drug, has moved to unseal court records in advance of a Food and Drug Administration (FDA) meeting to consider whether the drug should carry a warning about … Continue reading

Posted in Chantix, Pharmaceuticals |

FDA to Convene Panel on Smoking Cessation Drug, Chantix, Over Psychiatric, Behavioral Side Effect Risks

The U.S. Food and Drug Administration (FDA) announced that it plans to review Chantix, the smoking cessation drug, to determine if its quit smoking benefits exceed its psychiatric and behavioral risks, Approved in 2006, Chantix received the U.S. Food and … Continue reading

Posted in Chantix, Pharmaceuticals |

Motion denied to delay Chantix trial

The first trial alleging the stop-smoking drug Chantix causes serious and some life-threatening side effects will go forward as scheduled after a federal court judge denied a request by the drug’s maker to delay it in light of a new … Continue reading

Posted in Chantix, Health Concerns, Pharmaceuticals | Tagged |

BPA Side Effects May Be Long Lasting

A recent study suggests that the side effects of BPA may be long lasting. BPA, or bisphonel A, a controversial plastics chemical, has been linked to a growing and broad array of adverse health effects. In this study, the effects … Continue reading

Posted in Chantix, Legal News, Radiation Exposure Environmental Contamination |

U. Of Penn Researchers Testing Chantix Despite Risks

Despite its known risks, University of Pennsylvania researchers plan on testing the smoking cessation medication, Chantix (varenicline). The U.S. Food & Drug Administration (FDA) approved Chantix in 2006. Chantix blocks nicotine by targeting the brain’s nicotine receptors; however, about a … Continue reading

Posted in Chantix, Health Concerns, Pharmaceuticals |

Study Finds Chantix Linked to Suicidal Behavior, Depression More Frequently than Other Stop-Smoking Treatments

A team of researchers is calling on the U.S. Food & Drug Administration (FDA) to beef up warnings for < "http://www.yourlawyer.com/topics/overview/chantix_side_effects">Chantix (varenicline), after their study found the drug’s psychological side effects make it unsuitable for first-line use as a smoking-cessation … Continue reading

Posted in Chantix, Pharmaceuticals |

FDA Modifies Chantix Label for Heart, COPD Patients

The < "http://www.yourlawyer.com/topics/overview/chantix_side_effects">Chantix label has been updated with new information regarding the safety and efficacy of the smoking cessation medication, according to an announcement from the U.S. Food & Drug Administration (FDA). The modifications to the Chantix label apply to … Continue reading

Posted in Chantix, Pharmaceuticals |

Chantix Study Sees Significant Increase in Heart Risks

People taking < "http://www.yourlawyer.com/topics/overview/chantix_side_effects">Chantix (varenicline), Pfizer Inc.’s controversial stop-smoking drug, face a much higher risk of heart attacks, strokes and other serious cardiovascular events, according to a new study from researchers at Johns Hopkins University and Wake Forest Baptist Medical … Continue reading

Posted in Chantix, Pharmaceuticals |

Health Canada Reviewing Champix for Heart Side Effects

Health Canada is reviewing the smoking cessation drug Champix (sold as < "http://www.yourlawyer.com/topics/overview/chantix_side_effects">Chantix is the U.S.) for a possible link to heart problems. The Health Canada announcement follows last week’s notification by the U.S. Food & Drug Administration (FDA) that … Continue reading

Posted in Chantix, Pharmaceuticals |

© 2005-2016 Parker Waichman LLP ®. All Rights Reserved.